| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Sep 1, 2026 | Disposed to issuer(D) | 23K | $85.00 | $1.9M | 6K |
| Sep 1, 2026 | Disposed to issuer(D) | 6K | $85.00 | $504K | 0 |
| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Sep 1, 2026 | Disposed to issuer(D) | 2K | $83.09 | $174K | 0 |
| Sep 1, 2026 | Disposed to issuer(D) | 18K | $64.68 | $1.1M | 0 |
| Sep 1, 2026 | Disposed to issuer(D) | 13K | $40.29 | $504K | 0 |
| Sep 1, 2026 | Disposed to issuer(D) | 10K | $52.67 | $545K | 0 |
| Sep 1, 2026 | Disposed to issuer(D) | 10K | $49.13 | $478K | 0 |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-059902) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Crinetics Pharmaceuticals, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.